- ►diabetesjournals.org FC Sasso, O Carbonara, M Persico, D Iafusco, T … - Diabetes Care, 2002 - Am Diabetes Assoc OBJECTIVE—ACE inhibitors delay the progression from incipient to overt diabetic nephropathy
and reduce albumin excretion rate (AER), independently of blood pressure. Angiotensin II type
1 receptor antagonists produce similar effects on microalbuminuria and mean arterial ... Cited by 49 - Related articles - BL Direct - All 8 versions
- ►annals.org [PDF] … , MGA Baggen, SWJ Lamberts, AH Bootsma … - Annals of internal …, 2003 - Am Coll Physicians Background: Angiotensin-converting enzyme inhibitors have shown antiproteinuric effects in
normotensive and hypertensive diabetic patients. Angiotensin-receptor antagonists reduce urinary
albumin excretion and the risk for renal and cardiovascular com- plications in ... Cited by 59 - Related articles - BL Direct - All 10 versions
K Malmqvist, T Kahan, M Edner, L Bergfeldt - The American journal of cardiology, 2002 - Elsevier Left ventricular (LV) hypertrophy is associated with a substantial risk for malignant arrhythmias
and sudden death. The effects of antihypertensive therapy on QT dispersion, which reflects cardiac
repolarization heterogeneity, in relation to changes in LV mass has not been well studied. ... Cited by 33 - Related articles - All 6 versions
TA Simon, RT Gelarden, SA Freitag, KB Kassler- … - The American journal of …, 1998 - Elsevier Nine multicenter, randomized, placebo-controlled studies were conducted to evaluate the safety
and tolerability of the angiotensin II subtype 1 receptor blocker (AT 1 blocker) irbesartan for the
treatment of mild to moderate hypertension. After a 4- to 5-week placebo lead-in phase, ... Cited by 57 - Related articles - BL Direct - All 9 versions
P Howe, P Phillips, R Saini, K Kassler- … - Clinical and …, 1999 - informahealthcare.com Page 1. Page 2. Page 3. Page 4. Page 5. Page 6. Page 7. Page 8. Page 9. Page 10. Page
11. Page 12. 1384 HOW ET AL. reduced daytime ADBP and ASBP readings compared
with placebo (p < 0.01 for all comparisons with placebo) [Table 21. ... Cited by 38 - Related articles - BL Direct - All 4 versions
[CITATION] In vitro N-glucuronidation of SR 474346 (BMS 186295), a new AT1 nonpeptide …
L Perrier, M Bourrié, E Marti, C Tronquet, D Massé, Y … - J Pharmacol Exp Ther, 1994 Cited by 6 - Related articles
F Schmitt, F Martinez, G Brillet, T Nguyen- … - Journal of …, 1998 - journals.lww.com In 10 healthy normotensive volunteers on a normal sodium diet, we evaluated the renal effects
of a single oral dose of 50 mg of irbesartan (SR 47436, BMS 186295), an angiotensin II AT 1
-receptor antagonist, in baseline conditions and during an exogenous angiotensin II ... Cited by 20 - Related articles - BL Direct - All 4 versions
[CITATION] Effects of antacids on irbesartan pharmacokinetics [abstract no. FC-9]
M Escolar, A López de Ocariz, M Simón… - Meth Find Exp Clin Pharmacol, 1998 Cited by 9 - Related articles
T Littlejohn, RS Phd, K Kassler-Taub, SC … - Clinical and …, 1999 - informahealthcare.com Thomas Littlejohn 111, MD,' Ravi Saini, PhD: Kenneth Kassler-Taub, MD? SG Chrysant, MD3
and T Marbury, MD4 'Piedmont Medical Research Associates, Winston-Salem, NC. 'Bristol-Myers
Squibb Pharmaceutical Research Institute, Princeton, NJ. 30klahoma Cardiovascular and ... Cited by 23 - Related articles - BL Direct - All 5 versions
